Call Options

25 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $231,642 - $288,006
300 Added 0.96%
31,700 $28.1 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $3.33 Million - $4.18 Million
4,600 Added 17.16%
31,400 $28.4 Million
Q1 2024

May 01, 2024

SELL
$592.2 - $792.28 $13.9 Million - $18.6 Million
-23,500 Reduced 46.72%
26,800 $20.8 Million
Q4 2023

Feb 12, 2024

BUY
$525.19 - $619.13 $8.35 Million - $9.84 Million
15,900 Added 46.22%
50,300 $29.3 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $1.26 Million - $1.74 Million
2,900 Added 9.21%
34,400 $18.5 Million
Q2 2023

Aug 10, 2023

BUY
$350.74 - $468.98 $1.44 Million - $1.92 Million
4,100 Added 14.96%
31,500 $14.8 Million
Q1 2023

May 09, 2023

SELL
$310.63 - $364.82 $8.17 Million - $9.59 Million
-26,300 Reduced 48.98%
27,400 $9.41 Million
Q4 2022

Feb 10, 2023

BUY
$321.55 - $374.67 $353,705 - $412,137
1,100 Added 2.09%
53,700 $19.6 Million
Q3 2022

Nov 10, 2022

BUY
$296.48 - $337.87 $2.16 Million - $2.47 Million
7,300 Added 16.11%
52,600 $17 Million
Q2 2022

Aug 15, 2022

SELL
$278.73 - $327.27 $12.9 Million - $15.1 Million
-46,200 Reduced 50.49%
45,300 $14.7 Million
Q1 2022

May 13, 2022

SELL
$234.69 - $291.66 $657,132 - $816,648
-2,800 Reduced 2.97%
91,500 $26.2 Million
Q4 2021

Feb 11, 2022

SELL
$224.85 - $279.04 $6.97 Million - $8.65 Million
-31,000 Reduced 24.74%
94,300 $26 Million
Q3 2021

Nov 15, 2021

SELL
$221.6 - $272.71 $930,720 - $1.15 Million
-4,200 Reduced 3.24%
125,300 $29 Million
Q2 2021

Aug 16, 2021

SELL
$180.55 - $233.54 $3.86 Million - $5 Million
-21,400 Reduced 14.18%
129,500 $29.7 Million
Q1 2021

May 17, 2021

BUY
$164.32 - $212.72 $10.6 Million - $13.7 Million
64,400 Added 74.45%
150,900 $28.2 Million
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $2.71 Million - $3.59 Million
20,800 Added 31.66%
86,500 $14.6 Million
Q3 2020

Nov 16, 2020

BUY
$146.22 - $169.13 $3.82 Million - $4.41 Million
26,100 Added 65.91%
65,700 $9.73 Million
Q2 2020

Aug 14, 2020

SELL
$136.42 - $164.18 $1.46 Million - $1.76 Million
-10,700 Reduced 21.27%
39,600 $6.5 Million
Q1 2020

May 15, 2020

SELL
$119.05 - $147.35 $6.5 Million - $8.05 Million
-54,600 Reduced 52.05%
50,300 $6.98 Million
Q4 2019

Feb 14, 2020

BUY
$106.92 - $132.43 $2.33 Million - $2.89 Million
21,800 Added 26.23%
104,900 $13.8 Million
Q3 2019

Nov 14, 2019

BUY
$106.79 - $116.16 $2.64 Million - $2.87 Million
24,700 Added 42.29%
83,100 $9.29 Million
Q2 2019

Aug 14, 2019

SELL
$110.79 - $129.32 $221,580 - $258,640
-2,000 Reduced 3.31%
58,400 $6.47 Million
Q1 2019

May 15, 2019

SELL
$111.31 - $131.02 $3.39 Million - $4 Million
-30,500 Reduced 33.55%
60,400 $7.84 Million
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $921,330 - $1.03 Million
8,700 Added 10.58%
90,900 $10.5 Million
Q3 2018

Nov 14, 2018

BUY
$85.86 - $107.31 $7.06 Million - $8.82 Million
82,200 New
82,200 $8.82 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Capstone Investment Advisors, LLC Portfolio

Follow Capstone Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.